Xarelto Internal Bleeding Lawsuits

If you were using Xarelto (rivaroxaban) and were seriously injured or a family member took the drug and died, you should talk to an experienced lawyer about your potential claims against the drug maker. Xarelto was developed by Bayer, and Johnson & Johnson’s New Jersey-based unit Janssen Pharmaceuticals obtained FDA approval in 2011.

Xarelto was the second anticoagulant, or blood thinner, in a new class of anticoagulants, known as "Factor Xa" drugs. Xarelto, and the other drugs in the Factor Xa class, has been found to increase the consumer’s risk of severe injury and wrongful death. Often, the blood of oral anticoagulant users will become “too thin,” requiring an adjustment of the patient’s dosage. Xarelto neither requires ongoing medical monitoring of blood levels nor does it have an approved antidote whereby doctors can reverse the effects of the excessive bleeding caused by the drug.

What is Xarelto?

Xarelto is one of the first drugs in a new class of oral anticoagulants. Initially developed for the prevention of deep vein thrombosis and pulmonary embolism after knee replacement surgery, Xarelto has also been approved to lower the risk of stroke in people with irregular heartbeat (atrial fibrillation).

After Xarelto increased in popularity in 2011, a significant number of patients and doctors began reporting incidents of uncontrollable hemorrhaging that led to serious injury requiring hospitalization and transfusion, and even death.

Clinical Misconduct

A recent report found evidence of clinical misconduct throughout Xarelto's trials. This misconduct includes the falsification and destruction of data pertaining to the safety of the Factor Xa class anticoagulants.

The Food and Drug Administration (FDA) found that one trial (RECORD 4) was so rife with dubious behavior and scientific misconduct, that it rejected the report during the approval process of the drug.

Additionally, FDA inspections found that researchers failed to:

  • report adverse events affecting patients,
  • maintain adequate medical records,
  • obtain adequate consent from subjects, and
  • report unanticipated risks to subjects.

Xarelto Injury Litigation

As a leading mass tort law firm, Watts Guerra LLP is reviewing potential claims for clients who have suffered from, or lost a family member to, severe bleeding problems caused by Xarelto.

The attorneys at Watts Guerra have successfully handled thousands of pharmaceutical injury cases nationally. You need a firm with experience to handle a serious injury or death and Mikal Watts is one of the most successful pharmaceutical injury lawyers in the country.

Mr. Watts has handled several pharmaceutical and medical device cases, including Pradaxa, Transvaginal Mesh, Ortho-Evra, Vioxx, Fen Phen, Rezulin, Zyprexa and various hip implants.

If you’ve suffered as a result of Xarelto side effects, let Watts Guerra LLP help you and your family. Contact the firm now.

Free Case Evaluation

Disclaimer | Privacy Policy

Bookmark and Share

Mikal C. Watts

Mikal C. Watts Mikal C. Watts is one of the most successful pharmaceutical lawyers in the country. He has handled many mass torts, including Ortho-Evra, Vioxx, Fen Phen, Rezulin, Zyprexa, and Sulzer hip implants. Mr. Watts leads a team of successful trial lawyers who handle pharmaceutical product liability cases across the country.
Contact us using our online form, or call us toll-free at 1(800)796-9605.